Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Ringer's Lactate is an intravenous crystalloid solution that serves as a variation of the standard Ringer's Lactate (also known as Hartmann's Solution). It is typically composed of sodium chloride, sodium lactate, potassium chloride, and calcium chloride, with modifications involving adjustments to electrolyte concentrations or the addition of components like dextrose to meet specific clinical or experimental requirements. In the context of clinical research, such as trials evaluating cardioprotective agents like Intralipid during cardiac surgery, modified versions are often utilized as control solutions or placebos, sometimes specifically formulated by hospital pharmacies to match the appearance of the active intervention. The solution functions by expanding intravascular volume and providing essential electrolytes, while the lactate component acts as a precursor to bicarbonate, helping to maintain acid-base balance and treat metabolic acidosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified ringer's lactate.